Funding Rounds
Engimmune Therapeutics

Engimmune Therapeutics Seed (2022, $15M)

Engimmune Therapeutics

Platform engineering next-generation T cell receptor therapies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $15.80M

Investors